J. Tobian

发表

The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.

P. Scuffham, A. Shearer, A. Gordois, 2003 .

Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.

J. Gross, Z. Milicevic, J. Tobian, 2009, Diabetes technology & therapeutics.

Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.

S. Garg, C. Mathieu, J. Gates, 2009, Diabetes technology & therapeutics.

The health care costs of diabetic peripheral neuropathy in the US.

P. Scuffham, A. Shearer, A. Gordois, 2003, Diabetes care.

Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

Jang Ik Cho, J. Bue-Valleskey, N. Schloot, 2021, Diabetes Therapy.

The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)

Michael S. Reidy, Shawn S. Stephens, Bartholomew E. Clark, 2022, BMC Nutrition.

Diabetes in African American women: the silent epidemic.

M. Quinn, J. Tobian, W. McNabb, 1997, Women's health.

Association of Metformin With the Development of Age-Related Macular Degeneration.

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, JAMA ophthalmology.

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

C. Champagne, J. Lovejoy, E. Tucker, 2000, Diabetes care.

The impact of diabetes and age on pulmonary function: data from the National Health and Nutrition Examination Survey.

R. Crapo, R. Jensen, J. Tobian, 2009, Diabetes research and clinical practice.

Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program

Michael S. Reidy, Bartholomew E. Clark, Denise R. Anderson, 2012, PLoS genetics.

Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program

D. Ehrmann, J. Tobian, Margaret J. Matulik, 2012 .

Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

Claresa Levetan, Bruce Bode, J. Mastrototaro, 2004, Mayo Clinic proceedings.

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study

J. Bue-Valleskey, D. Cao, J. Miura, 2020, Diabetes, obesity & metabolism.

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO‐Pump‐2

Jang Ik Cho, M. Phillip, T. Hardy, 2020, Diabetes, obesity & metabolism.

The Health Care Costs of Diabetic Peripheral Neuropathy in the

P. Scuffham, A. Shearer, A. Gordois, 2003 .

Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.

M. Lawrence, C. Heilmann, J. Tobian, 2009, Diabetes technology & therapeutics.

The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic data.

B. Silverman, D. Muchmore, J. Tobian, 2007, Diabetes technology & therapeutics.

Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

Michael S. Reidy, Tanya M. Teslovich, Anne W. Ndungu, 2023, Diabetologia.